Edward P. Gelmann, MD, is a professor of medicine in the Division of Hematology and Oncology at the University of Arizona College of Medicine – Tucson and holds the John Norton Endowed Chair for Prostate Cancer Research. Dr. Gelmann recently moved to Arizona from New York City where he had been a professor of medicine, pathology and cell biology as well as deputy director of the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center. He primarily cares for patients with genitourinary malignancies that include prostate, testicular, bladder and renal cell cancers.
Dr. Gelmann graduated magna cum laude with a bachelor’s degree from Yale University, in New Haven, Conn. He earned his medical degree at Stanford University School of Medicine, afterward receiving his internal medicine training at the University of Chicago Hospitals and Clinics. He then joined the U.S. Public Health Service to train as a medical oncology fellow at the National Cancer Institute in Bethesda, Md.
After becoming an established researcher at the NCI through his work in the molecular biology of solid tumors, Dr. Gelmann moved to Georgetown University where he assumed the role of chief of the Division of Hematology/Oncology. He then headed to Columbia University, where he served as chief of the Division of Hematology/Oncology and then deputy director of the cancer center. He continues his research on the molecular biology of prostate cancer. His laboratory has made major contributions to understanding of the genetic steps that transform a normal prostate cell to a cancer cell.
Dr. Gelmann also remains actively involved in oncology patient care, in pre- and postdoctoral education, and in teaching graduate students, house staff and fellows.
Dr. Gelmann serves as Editor-in-Chief of the journal Endocrine Oncology.
Molecular biology of prostate cancer